U.S. – FDA rejects booster plans for general population

U.S. - FDA rejects booster plans for general population

U.S. – FDA rejects booster plans for general population

An influential advisory panel in the U.S. rejected a plan on Friday to offer the Pfizer vaccine’s booster shots against Covid-19 to most Americans, dealing a blow to President Joe Biden’s efforts to shore up people’s protection amid the spread of the highly contagious Delta variant of the virus.

The panel, however, voted in favour of authorising Pfizer vaccine boosters for everyone aged 65 and above, as well as for people at high risk of developing severe Covid-19.

The CDC has said it is considering boosters for older people, nursing home residents and front-line health care workers, rather than all adults.The FDA and CDC will most likely decide at some later point whether people who received the Moderna or Johnson & Johnson shots should get boosters. 

Earlier this week, two top FDA vaccine reviewers joined a group of international scientists in publishing an editorial rejecting the need for boosters in healthy people. The scientists said studies show the shots are working well.